Business
Medical Care Technologies Inc. (OTC Pink: MDCE) Announces Completion of Readiness Testing for AI-Powered Skin Lesion Pre-Screening Mobile Application
Medical Care Technologies Inc. (OTC Pink: MDCE) Announces Completion of Readiness Testing for AI-Powered Skin Lesion Pre-Screening Mobile Application.
About this update from Medical Care Technologies Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Medical Care Technologies Inc. (OTC Pink: MDCE) Announces Completion of Readiness Testing for AI-Powered Skin Lesion Pre-Screening Mobile Application\r\n \r\n \r\n\r\n\r\nMedical Care Technologies Inc. (OTC Pink: MDCE) Announces Completion of Readiness Testing for AI-Powered Skin Lesion Pre-Screening Mobile Application\r\n\r\n\r\n\r\n\r\n\r\nMESA, ARIZONA / ACCESS Newswire / January 5, 2026 / Medical Care Technologies Inc. (OTC Pink:MDCE) announced today that the Company has successfully completed its internal readiness testing phase for its forthcoming AI-powered mobile application designed for skin lesion pre-screening and risk-awareness. The mobile application is scheduled for public release later this year.\r\n The application utilizes AI-driven visual analysis tools to help users identify skin features that may warrant clinical attention. The system is designed to assist with lesion and anomaly pattern observation, including:\r\n \r\n asymmetric vs. symmetric spot characteristics\r\n uneven or irregular borders\r\n multiple color variations within a lesion\r\n ulceration indicators or surface bleeding characteristics\r\n general visual anomaly detection\r\n areas that appear \"different than surrounding skin\"\r\n \r\n The application is designed as an educational and awareness tool only. It is not a diagnostic device, does not provide medical advice, and encourages users to seek qualified clinical evaluation whenever atypical features are identified.\r\n \"We believe AI can empower people to be more proactive about their health by increasing awareness and encouraging early consultation with licensed clinicians,\" said Marshall Perkins III, CEO of Medical Care Technologies Inc.\"Completing readiness testing for our skin lesion pre-screening application represents a major milestone. This is the second in a growing suite of AI-powered mobile applications we are building, and we expect the first of these applications to launch to the public in the coming weeks.\"\r\n Medical Care Technologies is currently developing multiple AI-based mobile applications, including tools for lifestyle, wellness, nutrition insight, and early pattern detection in chronic illness risk factors. The Company's strategy is focused on expanding rapidly into international markets with scalable AI mobile applications.\r\n The Company's...